IRIS
ARTESE, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.811
EU - Europa 1.018
AS - Asia 869
SA - Sud America 64
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 3.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.738
SG - Singapore 552
IT - Italia 465
CN - Cina 230
DE - Germania 162
GB - Regno Unito 99
FI - Finlandia 92
SE - Svezia 79
CA - Canada 62
BR - Brasile 53
UA - Ucraina 45
IN - India 43
EE - Estonia 20
ES - Italia 13
FR - Francia 9
JP - Giappone 9
CZ - Repubblica Ceca 8
MX - Messico 7
NL - Olanda 7
VN - Vietnam 7
HK - Hong Kong 6
EU - Europa 5
TR - Turchia 5
IR - Iran 4
DZ - Algeria 3
PL - Polonia 3
UY - Uruguay 3
AL - Albania 2
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
IL - Israele 2
KE - Kenya 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
AM - Armenia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IQ - Iraq 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 3.781
Salva come PNG Salva come JPEG
Città #
Chandler 336
Singapore 209
Santa Clara 153
Munich 134
Milan 130
Lawrence 124
Princeton 124
Ashburn 120
London 74
Wilmington 70
Helsinki 55
Chicago 54
Ottawa 54
Des Moines 46
Catanzaro 40
Turku 27
Shanghai 26
Los Angeles 22
Washington 19
Guangzhou 15
Pune 15
Beijing 12
Rome 11
Shenzhen 11
Redmond 10
San Francisco 10
Norwalk 9
Casoria 8
Olomouc 8
San Nicola Manfredi 8
Boardman 7
Cagliari 7
Naples 7
Brooklyn 6
Crotone 6
Hanover 6
Jyväskylä 6
Messina 6
New York 6
Seattle 6
Tokyo 6
Weihai 6
Catania 5
Dallas 5
Hong Kong 5
Luni 5
Palermo 5
Phoenix 5
Redwood City 5
San Mateo 5
São Paulo 5
The Dalles 5
Wuhan 5
Anagni 4
Aversa 4
Charlotte 4
Chennai 4
Council Bluffs 4
Dongyang 4
Heidesheim 4
Jiaxing 4
Santander 4
Siena 4
Treviso 4
Vallefiorita 4
Afragola 3
Avola 3
Bonn 3
Boston 3
Castrovillari 3
Cosenza 3
Denver 3
Ferrara 3
Fuzhou 3
Giulianova 3
Jinan 3
Lamezia Terme 3
Latina 3
Montevideo 3
Padova 3
Pavia 3
Rui'an 3
San Cristóbal de La Laguna 3
Sellia Marina 3
Soverato Marina 3
Vasto 3
Xi'an 3
Agrigento 2
Amaroni 2
Amsterdam 2
Assago 2
Atlanta 2
Bagnoli di Sopra 2
Bari 2
Bathinda 2
Bengbu 2
Bogotá 2
Brasília 2
Buffalo 2
Ca Mau 2
Totale 2.204
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 177
GBPM: applicazione al docking molecolare 72
A Candidate multi-targeting approach to block the CD98hc oncoprotein 64
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 62
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 58
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 52
A Computational pathway toward the rational design of azinomycin analogues 51
Back Cover: Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement (ChemMedChem 16/2016) 49
Chemioterapici antifungini 48
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 48
Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations 46
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 45
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 45
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 44
Identification and Characterization of New DNA G-Quadruplex Binders Selected by a Combination of Ligand and Structure-Based Virtual Screening Approaches 44
Characterization and Structural Analysis of Novel Mutations in HIV-1 Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside Inhibitors 43
Identification and Structural Characterization of Novel Genetic Elements in HIV-1 - V3 Loop Regulating Co-Receptor Usage 42
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 42
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 41
Molecular recognition of a carboxy pyridostatin towards G-quadruplex structures: why does it prefer RNA? 41
A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences 40
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 40
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures 39
In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes 39
Characterization of the role of two additional HIV-1 reverse transcriptase mutations in the regulation of NNRTI resistance 39
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 39
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures 38
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 38
Comparison of molecular dynamics simulations carried out on wild type and mutants of HIV-1 reverse transcriptase 38
Characterization and structural analysis of HIV-1 integrase conservation 38
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 38
Computer-based techniques for lead identification and optimization II: Advanced search methods 37
Computational analysis of human immunodeficiency virus (HIV) type-1 reverse transcriptase crystallographic models based on significant conserved residues found in highly active antiretroviral therapy (HAART)-treated patients 36
From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds 35
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 35
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 34
CoMFA studies of non covalent monoamine oxidase inhibitors 34
Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics 34
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 33
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 33
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 32
Indagine statistica sulla diffusione nell’Industria farmaceutica italiana di tecnologie computazionali avanzate orientate alla progettazione di nuovi farmaci 32
Metodi computazionali e nutraceutica 32
Dinamica molecolare di complessi della proteasi di HIV-1: influenza di mutazioni associate a resistenza sulla ricognizione molecolare 32
Computational analysis of HIV-1 reverse transcriptase complexes 32
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage 31
Comparison of Computational Methods in Docking Experiments of G-Quadruplex Binders 31
Computer-based techniques for lead identification and optimization i: Basics 31
Conformational analysis of bioactive conformations in the drug discovery process 30
Computational study on DNA G-quadruplex binding compounds 30
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 30
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 29
Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders 29
Progettazione razionale di agenti bisalchilanti del DNA analoghi delle azinomicine 29
Natural products extracted from fungal species as new potential anti-cancer drugs: A structure-based drug repurposing approach targeting HDAC7 29
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 28
Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors 28
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors 28
Conformation and stability of intramolecular telomeric g-quadruplexes: sequence effects in the loops 28
Design and Synthesis of a (N-Alkylaminoalkyl-Substituted) Arylalkenylamide Drug Discovery Library 28
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 28
null 28
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase 27
Identification of new G-quadruplex binders by combined virtual screening approaches. 27
Computational approaches for discovery and optimization of G-quadruplex binders 27
High-throughput lipophilicity screening of opioid-like analgesics: validation of computational methods by means of RP-HPLC analysis 26
GBPM analysis of HIV-1 reverse transcriptase–DNA crystallographic complexes focused on the enzyme conserved regions of HAART-treated patients 26
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control 26
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation 25
Hit identification of novel DNA-quadruplex ligands 25
Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach 25
Docking e virtual screening su composti naturali: esempi su quercitina e cucurbitacina 24
Docking studies of Lopinavir, Atazanavir and Darunavir binding modes to HIV-1 protease mutants 24
Composti per il G-quadruplex a struttura naftilimmidica 24
Rational drug design of DNA cross-linking agents 23
Molecular Recognition Of Dna G-Quadruplex Ligands By Different Docking Methods 22
STATISTICAL ANALISYS OF DRUG DESIGN COMPUTATIONAL TECNIQUES AMONG THE RESEARCH GROUPS IN ITALY 22
Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies 22
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 22
The polymorphisms of DNA g-quadruplex investigated by docking experiments with telomestatin enantiomers 22
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T). 22
Molecular interaction fields in drug discovery: recent advances and future perspectives 21
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 20
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 20
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance 20
Indagine statistica sulla diffusione delle tecnologie computazionali avanzate per la progettazione dei nuovi farmaci 19
Studio computazionale su modelli PDB di HIV-1 19
Rational drug design of DNA G-quadruplex binders using structure-based computational approaches. 19
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 19
Molecular docking, synthesis and biological evaluation of indomethacin analogs as novel cyclooxygenase inhibitors. 19
Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance 18
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 18
Rational drug design of DNA G-quadruplex binders using in silico approaches 18
Docking comparativo per lo sviluppo di ligandi per il DNA G-Quadruplex 18
Structural analysis against HCV polymerase in presence of natural resistance-associated substitutions in HCV isolates from DAA-naïve patients 18
An overview on olfaction in the biological, analytical, computational, and machine learning fields 18
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021 17
Rational Design, Synthesis, Biophysical and Antiproliferative Evaluation of Fluorenone Derivatives with DNA G-Quadruplex Binding Properties 17
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors 16
Molecular models of HIV-1 targets/drugs 16
Totale 3.317
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.435
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 7 3 20 20 27 20 23 4 16 13 8 4
2021/2022331 4 2 10 64 23 6 14 80 22 33 69 4
2022/20231.003 253 48 46 72 111 72 9 70 156 59 83 24
2023/2024513 72 57 46 31 33 152 12 45 4 21 16 24
2024/20251.709 204 143 65 59 117 199 92 66 221 119 155 269
2025/20261 1 0 0 0 0 0 0 0 0 0 0 0
Totale 3.873